The US Food and Drug Administration (FDA) has approved Baraclude (entecavir) tablets and oral solution for use in the treatment of chronic hepatitis B virus (HBV) infection in adults. Entecavir is a guanosine nucleoside analogue with selective activity against HBV.
This month's column includes a summary of the following:
Ammonul (sodium phenylacetate and sodium benzoate) Injection
Baraclude (entecavir) Tablets and Oral Solution
Namenda (memantine) Oral Solution
Retisert (fluocinolone acetonide) Intravitreal Implant
Fosamax Plus D (alendronate and vitamin D3) Tablets
Asmanex Twisthaler (mometasone furoate) Inhaler
Medscape Pharmacists. 2005;6(1) © 2005 Medscape
Cite this: May 2005 - Medscape - May 05, 2005.